CHARGED ALPHATMFrontier AI stock research

ALGN · NasdaqGS

Align Technology, Inc.

Medical Instruments & Supplies · United States

USD 143.071.7% daily changeQuote 2026-10-06 · USD
Market cap (USD)
US$10.16B
Trailing P/E
24.88x
Forward P/E
11.46x
Quarterly revenue growth
4.3%
Trailing net margin
10.0%
Indicated dividend yield
—

Snapshot 2026-10-06 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-10-28 (provider estimate, not issuer-confirmed).

Company background

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Company website

Q1 2026

Go beyond the headline.

ALGN Stock: Q1 2026 Earnings Analysis

Published 2026-05-01

Comparable businesses

ALGN peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricALGNAlign Technology, Inc.Snapshot 2026-10-06Financial period: 2026-06-30COOThe Cooper Companies, Inc.Snapshot 2026-10-06Financial period: 2026-07-31BAXBaxter International Inc.Snapshot 2026-10-06Financial period: 2026-06-30Peer medianSimilar-size peers only
Market capMarket value, converted to USDUS$10.16BUS$10.67BUS$12.56BUS$11.62Bn=2
Forward P/EProvider forward earnings estimate11.46x11.96x11.93x11.94xn=2
EV / EBITDAEnterprise value / trailing EBITDA9.73x14.42x10.62x12.52xn=2
Revenue growthLatest quarter vs prior-year quarter4.3%0.6%5.3%2.9%n=2
Operating marginLatest reported quarter18.2%20.8%14.4%17.6%n=2
Free cash flow yieldTrailing cash flow / market cap5.8%5.1%8.0%6.5%n=2
Net debt / EBITDANet debt / trailing EBITDA-1.06x2.84x3.99x3.41xn=2
Debt / equityTotal debt / positive book equity0.03x0.34x1.56x0.95xn=2
Trailing P/ETrailing twelve-month earnings24.88x19.29x——
Price / bookPrice / positive book equity per share2.41x1.28x2.02x1.65xn=2
EV / salesEnterprise value / trailing revenue2.18x3.17x1.75x2.46xn=2
Earnings growthLatest quarter vs prior-year quarter-12.1%357.1%36.8%197.0%n=2
Gross marginTrailing twelve months70.7%65.9%34.1%50.0%n=2
Net marginTrailing twelve months10.0%13.5%-9.3%2.1%n=2
Return on equityProvider trailing return; positive equity only10.2%6.8%-14.4%-3.8%n=2
Free cash flow marginTrailing free cash flow / revenue14.4%12.8%8.7%10.8%n=2
Dividend yieldIndicated annual dividend / price——0.2%—
Earnings payoutProvider trailing dividend payout0.0%0.0%154.7%77.3%n=2
Current ratioCurrent assets / current liabilities1.40x1.22x1.95x1.58xn=2
BetaProvider historical market sensitivity1.670.820.650.74n=2

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-10-06. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for ALGN

All available reporting periods
Q1 20262026-05-01

ALGN Stock: Q1 2026 Earnings Analysis

Presentation · 2026-05-01 · YouTube

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.